| Role |
Name |
Disclosure |
Details |
| Author | John G Albertini, MD, Consulting Staff, Dermatologic Surgery, The Skin Surgery Center | Nothing to disclose | Details | | Coauthor | Victor J Marks, MD, Associate, Department of Dermatology, Section Chief, Dermatologic Surgery, Geisinger Health System | Nothing to disclose | Details | | Medical Editor | Russell Hall, MD, Chief, Professor, Department of Internal Medicine, Division of Dermatology, Duke University | Genetech Centecor | Details | | Pharmacy Editor | Richard P Vinson, MD, Assistant Clinical Professor, Department of Dermatology, Texas Tech University School of Medicine; Consulting Staff, Mountain View Dermatology, PA | Nothing to disclose | Details | | Managing Editor | Julia R Nunley, MD, Professor, Program Director, Dermatology Residency, Department of Dermatology, Virginia Commonwealth University Medical Center | Johnson and Johnson Amgen Forest Lab, Inc Galaxo Smith Klein Covidien Novartis Biolex | Details | | CME Editor | Joel M Gelfand, MD, MSCE, Medical Director, Clinical Studies Unit, Assistant Professor, Department of Dermatology, Associate Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania | AMGEN AMGEN Genentech Centocor Centocor Covance Shire | Details | | Chief Editor | Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| John G Albertini, Author |
The contributor discloses no conflict of interest. |
|